(0.64%) 5 160.85 points
(0.28%) 38 783 points
(0.69%) 16 267 points
(0.20%) $78.27
(4.20%) $2.23
(1.06%) $2 333.10
(3.43%) $27.61
(-0.04%) $964.95
(-0.07%) $0.928
(-0.43%) $10.83
(-0.16%) $0.796
(-0.10%) $91.36
-11.08% HKD 5.70
Live Chart Being Loaded With Signals
Lepu Biopharma Co., Ltd., a biopharmaceutical company, focuses on developing oncology therapeutics with a pipeline designed with a range of oncology products in China...
Stats | |
---|---|
Volumen de hoy | 9.66M |
Volumen promedio | 1.68M |
Capitalización de mercado | 9.15B |
EPS | HKD0 ( 2023-08-25 ) |
Próxima fecha de ganancias | ( HKD0 ) 2024-06-14 |
Last Dividend | HKD0 ( N/A ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -570.00 |
ATR14 | HKD0.0290 (0.51%) |
Volumen Correlación
Lepu Biopharma Co., Ltd. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Lepu Biopharma Co., Ltd. Correlación - Moneda/Commodity
Lepu Biopharma Co., Ltd. Finanzas
Annual | 2023 |
Ingresos: | HKD225.35M |
Beneficio Bruto: | HKD197.08M (87.45 %) |
EPS: | HKD-0.0133 |
FY | 2023 |
Ingresos: | HKD225.35M |
Beneficio Bruto: | HKD197.08M (87.45 %) |
EPS: | HKD-0.0133 |
FY | 2022 |
Ingresos: | HKD15.57M |
Beneficio Bruto: | HKD13.57M (87.12 %) |
EPS: | HKD-0.420 |
Financial Reports:
No articles found.
Lepu Biopharma Co., Ltd.
Lepu Biopharma Co., Ltd., a biopharmaceutical company, focuses on developing oncology therapeutics with a pipeline designed with a range of oncology products in China. The company develops oncology drug candidates, including antibody-drug conjugates (ADC), oncolytic virus drugs, and immunotherapies. It develops immuno-oncology products, such as HX008 Anti-PD-1 mAb and LP002 Anti-PD-L1 mAb; ADC products, including MRG003 EGFR-targeted ADC, MRG002 HER2-targeted ADC, MRG001 CD20-targeted ADC, MRG004A TF-targeted ADC, and CMG901 CLDNI8.2-targeted ADC; CG0070 oncolytic virus; and other drug candidates, such as HX008+OH2, LP002+OH2, and HX008+LP002. The company was incorporated in 2018 and is headquartered in Shanghai, China.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico